Management Team
Robin Winter-Sperry, M.D.
President & Chief Executive Officer
Dr. Robin Winter-Sperry serves as the President and CEO of Scientific Advantage, LLC, and Science Oriented Solutions. Her responsibilities include management and oversight of all of the combined entity’s strategy and business activities. In addition to serving as founder and president of Scientific Advantage for the past six years, Dr. Winter-Sperry has held a number of senior management and medical affairs positions at leading pharmaceutical companies. She created Novartis’ MSL department of Scientific Operations and Sanofi-Synthelabo’s Medical Therapeutic Liaison division. She has pioneered the recognition of MSLs as a specialty in the biopharmaceutical and device industry and is responsible for creating and developing many of the industry’s leading medical affairs and medical liaison teams. Dr. Winter-Sperry holds an assistant professorship in Dermatology at Mt. Sinai in Manhattan. She is a member of the Women’s Health and Counseling Center (WHCC) steering committee in Somerville, NJ. She was named in August 2005 by PharmaVoice to be one of the industry’s 100 most inspiring people. In 2006, she was elected to the Madison Who’s Who of Professionals. She has professional memberships in the American Academy of Dermatology. She has also been an active member of the Healthcare Business Women’s Association (HBA) for over 18 years, and is currently the HBA Mentor to the Metro chapter. She also holds the position of adjunct professor at the Rutgers Ernest Mario School of Pharmacy.
Sharon Huss, M.D.
Director of Strategic Medical Operations & Business Development
Dr. Sharon Huss is responsible for developing and implementing initiatives to expand and foster client relationships and exploring new business opportunities. She also creates new and innovative solutions to support and enhance companies’ existing medical affairs programs by realigning existing Medical Science Liaison (MSL) teams or creating complementary services. Prior to joining SOS, Dr. Huss was a medical information specialist with Cegedim-Dendrite, working on numerous projects for pharmaceutical clients, including Sanofi-Aventis and Bristol-Myers Squibb. She has also worked in clinical research and other areas within the healthcare industry. Dr. Huss obtained her medical degree from the University Iberoamericana (UNIBE), in the Dominican Republic. She speaks fluent Spanish, contributing to SOS’ focus on delivering comprehensive global programs.
Ian Bancroft
Vice President, Global MSL Programs
Ian Bancroft is responsible for program strategy, direction and tactical implementation of both domestic and international Medical Science Liaison (MSL) programs with SOS. As an expert in recruitment and training in the global healthcare market, he manages MSL field based teams worldwide, including recruitment, deployment, and training and development of MSLs and MSL team managers for client programs. In his current position, Ian ensures that MSL programs are tailored to the needs of individual countries and appropriate and adaptable to the many diverse market conditions and desires of local consumers. He also helps ensure that programs are designed to comply with varying local healthcare system guidelines. Prior to joining SOS, Ian held medical affairs positions with pharmaceutical companies including Pfizer, Pharmacia, and GD Searle, where he worked on global programs. Ian holds a Bachelor of Science in Physiology and Pharmacology from St. Andrews Scotland in the U.K., where he graduated with honors.
